ESMO CongressESMO Congress

The ESMO Congress is Europe's most prestigious and influential oncology conference, attracting over 30,000 professionals annually. Clinicians, researchers, patient advocates, journalists, and pharmaceutical industry representatives from around the world gather to share the latest developments in oncology and translate scientific breakthroughs into optimal cancer patient care.

The scientific program of the ESMO Congress is developed by a committee of over 300 international experts, covering topics ranging from basic research to the latest discoveries in cancer immunotherapy, from oncology nursing to palliative care, and from rare cancers to drug approvals.

The annual ESMO Congress serves as a premier global platform for translational research, presenting practice-changing data, and fostering multidisciplinary discussions. It offers an outstanding scientific education program and abundant networking opportunities for attendees.

The ESMO scientific and educational sessions provide a platform for showcasing cutting-edge clinical data, state-of-the-art educational updates, and unparalleled networking opportunities. Across more than 20 tracks covering all tumor types, treatment innovations, translational research, patient advocacy, and public policy, the congress delivers practice-changing data and high-quality education.

The ESMO Congress embodies the most advanced technologies and authoritative academic exchanges in the medical community. Experts and scholars from over 150 countries convene to share and discuss recent advances and trending topics in oncology diagnosis and treatment.